EcoDrugPlus

Ensembl ID : ML098612a
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : ML09922a
Gene Symbol: -
External references: -
104 Possible Orthologues:

Ensembl ID : ML10109a
Gene Symbol: -
External references: -
277 Possible Orthologues:

Ensembl ID : ML102215a
Gene Symbol: -
External references: -
146 Possible Orthologues:

Ensembl ID : ML102216a
Gene Symbol: -
External references: -
95 Possible Orthologues:

Ensembl ID : ML102219a
Gene Symbol: -
External references: -
57 Possible Orthologues:

Ensembl ID : ML102241a
Gene Symbol: -
External references: -
64 Possible Orthologues:

Ensembl ID : ML102253a
Gene Symbol: -
External references: -
115 Possible Orthologues:

Ensembl ID : ML10267a
Gene Symbol: -
External references: -
326 Possible Orthologues:

Ensembl ID : ML104328a
Gene Symbol: -
External references: -
92 Possible Orthologues:

Ensembl ID : ML105422a
Gene Symbol: -
External references: -
105 Possible Orthologues:

Ensembl ID : ML10592a
Gene Symbol: -
External references: -
58 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).